Changes of Ocular Structures After Hemodialysis in Patients With Chronic Kidney Diseases
1 other identifier
observational
40
0 countries
N/A
Brief Summary
To evaluate the effect of hemodialysis on various ophthalmologic parameters in patients with end-stage kidney disease (ESRD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 9, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 7, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 29, 2017
CompletedFirst Submitted
Initial submission to the registry
February 5, 2018
CompletedFirst Posted
Study publicly available on registry
February 15, 2018
CompletedFebruary 15, 2018
February 1, 2018
12 months
February 5, 2018
February 8, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
changes of retinal and choroidal thickness after hemodialysis
retinal \& choroidal thickness on OCT
immediately (within 10 minutes) before and after hemodialysis
Secondary Outcomes (2)
changes of foveal vascular density using optical coherence tomography-angiography (OCTA) after hemodialysis
immediately (within 10 minutes) before and after hemodialysis
the effect of hemodialysis (HD) on anterior chamber angle by anterior segment optical coherence
immediately (within 10 minutes) before and after hemodialysis
Study Arms (1)
patients with chronic kidney diseases
patients with end stage retinal disease undergoing hemodialysis underwent various ophthalmologic exams before and after hemodialysis.
Interventions
ophthalmologic exams such as vision, intraocular pressure, axial length and optical coherence tomography
Eligibility Criteria
patients with end-stage renal disease who undergoing hemodialysis
You may qualify if:
- \) patients who are regularly dialyzed in our dialysis room to participate in the study
- \) patients who agree with our study protocol
- \) patients who have unstable general condition
You may not qualify if:
- \) previous intraocular surgery, (2) baseline IOP greater than 22 mmHg, (3) presence of glaucomatous optic disc changes including excavation, thinning, or notching of the neuroretinal rim, (4) axial length greater than 26 mm, and (5) combined macular and retinal diseases such as central serous chorioretinopathy and age-related macular degeneration, except diabetic retinopathy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Heeyoon Cho, MD
Hanyang University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant professor
Study Record Dates
First Submitted
February 5, 2018
First Posted
February 15, 2018
Study Start
September 9, 2016
Primary Completion
September 7, 2017
Study Completion
December 29, 2017
Last Updated
February 15, 2018
Record last verified: 2018-02
Data Sharing
- IPD Sharing
- Will not share